Opioid and tachykinin receptors (TACRs) are closely related in addiction and pain processes. In zebrafish, opioid receptors have been cloned and characterized both biochemically and pharmacologically. However, the tacr1 gene has not yet been described in zebrafish. The aim of this research was to identify the tacr1 gene, study the effects of cocaine on tacr1, and analyze the interaction between tacr1 and opioid receptors. We have identified a duplicate of tacr1 gene in zebrafish, designated as tacr1a and tacr1b. Phylogenetic analyses revealed an alignment of these receptors in the Tacr1 fish cluster, with a clear distinction from other TACR1s of amphibians, birds, and mammals. Our qPCR results showed that tacr1a and tacr1b mRNAs are expressed during embryonic development. Whole-mount in situ hybridization showed tacr1 expression in the CNS and in the peripheral tissues. Cocaine (1.5 mM) induced an upregulation of tacr1a and tacr1b at 24 and 48 h post-fertilization (hpf; except for tacr1a at 48 hpf, which was downregulated). By contrast, HEK-293 cells transfected with tacr1a and tacr1b and exposed to cocaine showed a downregulation of tacr1s. The knockdown of ZfDOR2 and ZfMOR, opioid receptors, induced a down-and upregulation of tacr1a and tacr1b respectively. In conclusion, tacr1a and tacr1b in zebrafish are widely expressed throughout the CNS and peripherally, suggesting a critical role of these tacr1s during embryogenesis. tacr1a and tacr1b mRNA expression is altered by cocaine exposure and by the knockdown of opioid receptors. Thus, zebrafish can provide clues for a better understanding of the relationship between tachykinin and opioid receptors in pain and addiction during embryonic development.
Introduction
The biological actions of the tachykinin family -substance P (SP), neurokinin A (NKA) and NKB, hemokinin-1, and endokinins -are mediated by transmembrane G-proteincoupled receptors (GPCRs) and they have been classified within the NK 1 , NK 2 , and NK 3 receptor types (Regoli et al. 1994 , Maggi 2000 , Harrison & Geppetti 2001 , Pennefather et al. 2004 , which are encoded by tachykinin receptor 1 (TACR1), TACR2, and TACR3 genes respectively (Zhou et al. 2012) . SP, NKA, and NKB bind to NK 1 , NK 2 , and NK 3 receptors (also named TACR1, TACR2, and TACR3) respectively (Regoli et al. 1987 , Regoli et al. 1994 , DeVane 2001 , Harrison & Geppetti 2001 . NK 1 receptor (NK 1 R) is considered the SP receptor (Maggi 1995) . Several studies have shown that NK 1 is widely distributed throughout the CNS (basal ganglia, dorsal tegmental areas, inferior colliculus, olfactory bulb, hypothalamus, hippocampus, substantia nigra, cerebral cortex, septum, striatum, mesencephalon, medulla oblongata, and the dorsal horn of the spinal cord; Shults et al. 1984 , Maeno et al. 1993 and its activation has been implicated in different processes such as pain, synaptic transmission, neurogenic inflammation, neurotoxicity, mood disorder, stress, anxiety, and addiction (Regoli et al. 1994 , Harrison & Geppetti 2001 , Yu et al. 2002 , Gadd et al. 2003 , Gamboa-Esteves et al. 2004 , Commons 2010 .
The analgesic effect of opioids is mediated mainly by MOR (Matthes et al. 1996) but, as several studies have shown that MOR and NK 1 R are co-localized (Aicher et al. 2000a,b) and present interaction between them (Pfeiffer et al. 2003) , it is possible that analgesic effects of MOR can be modified by NK 1 R or vice versa. Moreover, in vitro experiments reported that MOR and NK 1 R form heterodimers in HEK-293 (NK 1 -MOR) where the activation of either type, by SP and DAMGO respectively, induces endocytosis (Pfeiffer et al. 2003) . Besides, it has also been described that NK 1 R activation by SP inhibits the endocytosis of MOR (Yu et al. 2009 ), indicating that SP and its receptor are involved in the modulation of MOR. Several studies have also shown that tachykinin and opioid systems are related in the addiction process, as NK 1 R and MOR are localized in different reward-related regions (Nakaya et al. 1994 , Pickel et al. 2000 , Garzó n & Pickel 2001 , Gadd et al. 2003 , Laurent et al. 2012 . Likewise, it has been suggested that SP acts in a similar manner to cocaine, producing an increase in dopamine neurotransmitter levels in the synaptic cleft (Kombian et al. 2009 ).
The tachykinin system has been cloned and characterized both biochemically and pharmacologically in different species (for reviews, see Maggi (1995) and Pennefather et al. (2004) ), and numerous investigations using the zebrafish have proven that this organism is a valuable vertebrate animal model for study of human diseases, pharmacology and drug discovery, and development studies in vertebrates (Chakraborty et al. 2009 , Lohi et al. 2012 , Santoriello & Zon 2012 . The study of the tachykinin system using the zebrafish could improve our understanding of different clinical situations where the tachykinin system is involved. This will also help to better understand of the interaction of the tachykinin system with other systems, like the opioids system that are involved in pain and addiction.
To date, the tachykinin system has not been described completely in zebrafish. Recently, the tac1, tac2, and tac3 precursors and the Tacr3s (Tacr3a1, Tacr3a2, and Tacr3b; Ogawa et al. 2012 , Zhou et al. 2012 ) have been cloned. Taking the above into consideration, we aimed to i) clone the tacr1 gene and study its expression during embryogenesis, ii) determine the evolutionary history of the tacr1s using phylogenetic analyses, iii) investigate the effects of cocaine on the tacr1s, and iv) study the interrelationship between the tachykinin system and opioid receptors during embryonic development.
Materials and methods

Animals
Adult zebrafish (AB strain) were maintained on a 14 h light:10 h darkness cycle at 26 8C at our Fish Facilities. Embryos were raised at 28.5 8C and maintained in dishes in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl, and 0.33 mM MgSO 4 in distilled water; Sigma). Embryo ages were expressed as hours post-fertilization (hpf). All procedures and experimental protocols were carried out in accordance with the guidelines of the European Communities Council directive of 24 November 1986 (86/609/EEC), and to the current Spanish legislation for the use and care of animals (BOE 252/34367-91, 2005) .
Drug treatment
Zebrafish embryos at 5 hpf were exposed to 1.5 mM cocaine hydrochloride (HCl) and were then collected at 24 and 48 hpf; both stages are important during zebrafish embryonic development: at 24 hpf, the CNS is being formed and differentiated and primary organogenesis is finished at 24 hpf. HEK-293 cells (expressing zebrafish TACRs) were treated with 1.5 mM cocaine HCl over 24 hpf. The doses of 1.5 mM cocaine HCl was chosen as this dose is comparable to the concentration present in human neonates (Dempsey et al. 1999) .
Cloning of tacr1a and tacr1b receptors in zebrafish
The PCR program used for tacr1a and tacr1b amplification was 5 min at 95 8C, followed by 35 cycles of 1 min at 95 8C, 1 min at 59 8C (for tacr1a) and 62 8C (for tacr1b), and 3 min at 72 8C and a final extension temperature of 72 8C for 10 min. PCR primers (Table 1) were based on the predicted sequences of the tacr1a and tacr1b genes from PubMed (XM_687377.2, XM_001343037.3). The desired tacr1a and tacr1b amplicons were subcloned using the pCRII vector (Invitrogen). TOP 10 0 F cells (Invitrogen) were transformed with the constructs, and miniprep (ZYMO Research Corporation, CA, USA) and midiprep (Sigma) were performed. These constructs of both tacr1a and tacr1b with pCRII were digested with KpnI and EcoRV for 1 h at 37 8C. Then, the purified products were sequenced using the T7 and SP6 sequencing primers.
Phylogenetic analyses
The prediction of the open reading frames (ORFs) and translations of tacr1a and tacr1b into amino acid sequences were performed using the ORF Finder program from SMS (http://www.bioinformatics.org/sms2/). The Tacr1a and Tacr1b amino acid sequences from zebrafish and other orthologs of several vertebrates were aligned in NBRF format using the ClustalW Software. Molecular Evolutionary Genetic Analysis (MEGA 5) was used to construct neighbor-joining (NJ) and maximum likelihood (ML) trees.
Expression of tacr1a and tacr1b from zebrafish in mammalian HEK-293 cells
In order to insert the DNA sequences of both tacr1a and tacr1b in-frame with the vector sequences, two restriction endonuclease (RE) sites from the multiple cloning sites of the plasmid vector were chosen: XhoI and KpnI for pEGFP-C3 (Clontech) and HindIII and SacII for pDsRed1-N1 (Clontech). The RE recognition sequences were added to the ends of the primers (extreme 5 0 -terminal), which were used to amplify the tacr1a and tacr1b ( Table 1 ). The vector and inserted genes were digested with both REs in a double digest for 1 h at 37 8C, and after their respective purification, the inserts were ligated using the TA cloning Kit (Invitrogen) in the plasmid vectors pEGFP-C3 (GFP) and pDs1Red-N1 (DsRed). The PCR program used for tacr1a and tacr1b amplification was 5 min at 95 8C, followed by 35 cycles of 45 s at 95 8C, 45 s at 64 8C, and 3 min at 72 8C and a final extension temperature of 72 8C for 10 min. Plasmid transfection was accomplished using the Effectene Transfection Reagent Kit (Qiagen). The expression vectors encoded neomycin/kanamycin resistance, which permitted us to select and obtain stable clones of tacr1a and tacr1b with 0.5 mg/ml geneticin (Gibco BRL). After an w2-month selection period, stably transfected HEK-293 cells expressing tacr1a-GFP and tacr1b-DsRed were grown in DMEM supplemented with 10% FCS, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 0.25 mg/ml geneticin at 37 8C under a 5% CO 2 atmosphere. HEK-293 cells expressing tacr1a-GFP and tacr1b-DsRed were exposed to 1.5 mM cocaine HCl for 24 hpf.
RNA extraction, retrotranscription, and real-time PCR (qPCR)
Total RNA from the embryos and HEK-293 cells was extracted using TRIzol reagent (Invitrogen), following the protocol recommended by the manufacturers. In all cases, RNA samples were treated with DNase I (Roche) at 37 8C for 15 min. The quantity and quality of the RNA were determined by measuring absorbance at 260 nm and 260 nm/280 nm, using NanoDrop 2000C (Thermo Fisher Scientific, Waltham, MA, USA). cDNA synthesis was carried out by retrotranscription (RT) of total RNA to cDNA using the Promega RT Kit, following the protocol recommended by the manufacturers. The cDNA samples were then treated with RNase A (20 ng/ml for 7-8 mg cDNA) for 20 min at 37 8C. Following this, these products were purified using the QIAquick PCR Purification Kit (Qiagen) and eluted in DNase-free water. The oligonucleotides used for qPCR experiments are listed in Table 1 . qPCR products were measured using the curve of the SYBR-Green method. SYBR-Green was included in a 2! Master Mix from Applied Biosystems (SYBR Green dye, dNTPs, Passive Reference (ROX), Amplitaq1 Gold DNA polymerase). The ABI Prism 7300 detection system (Applied Biosystems) was used to amplify the different genes. The final volume of each reaction was 20 ml: 10 ml Master Mix, 1 ml of each oligonucleotide, 7 ml distilled water, and 1 ml cDNA at a concentration of 5 ng/ml. Standard curves for absolute quantification were performed for the different genes studied in zebrafish embryos. A basic PCR method was implemented to amplify the fragments of the different genes to be studied. PCR products were visualized on agarose gel and the fragment corresponding to each gene was cut from the agarose gel and purified. Serial 1:10 dilutions were made from the purified PCR product, ranging from 10 K2 to 10 K5 ng/ml and chosen according to their cycle quantification (Cq) values and considering that perfect amplification had been obtained when the difference in the Cq values from one dilution to the next was close to 3.3, which afforded a four-point straight line with a slope of K3.3.
Spatial expression of tacr1a and tacr1b mRNA
The constructs of both tacr1a and tacr1b with pCRII were linearized by EcoRV and KpnI digestion respectively over 1 h at 37 8C. From the linearized tacr1a and tacr1b DNAs, antisense RNAs were transcribed with T7 and SP6 promoters respectively and the RNAs were also labeled with digoxigenin. These latter products were treated with DNase I (Roche) and purified. The riboprobe (600 ng/ml) was diluted in the prehybridization solution for the in situ hybridization (ISH) experiments. Embryos at 24 and 48 hpf were dechorionated, fixed with 4% paraformaldehyde (PFA) in PBS overnight at 4 8C, washed twice in PBS, 5 min each, at room temperature, and finally maintained in absolute methanol at K20 8C until use. The following day, the embryos were rehydrated in consecutive dilutions of methanol/PBS (75, 50, and 25%), 5 min for each dilution. These were washed four times for 5 min each in 100% PBS-Tween 20 (0.2%; PBT). Proteinase K (10 mg/ml) was used to permeabilize the embryos at room temperature over 20 min for 24 hpf embryos and 40 min for 48 hpf embryos. Proteinase K digestion was stopped by incubating the embryos for 20 min in 4% PFA in 1!PBS. Four washes, 5 min/wash, in 1!PBT were performed to remove residual PFA. After 2 h of prehybridization with tacr1a and tacr1b riboprobe, the embryos were left overnight at 64 8C to hybridize. Washes were performed every 20 min in each wash solution with prehybridization/Tris-buffered saline (TBS; 50%/50%) and TBS-Tween 20 (0.2%; TBST) over 2 h. Then, the embryos were blocked with blocking buffer (goat serumCTBST) for 2 h and were incubated overnight with antidigoxigenin antibody conjugated with alkaline phosphatase (1:3000, Roche) at 4 8C. The following day, the embryos were washed with Xpho solution (1 M Tris-HCl, pH 9.5, 1 M MgCl 2 , 4 M NaCl, and 20% Tween 20) for 10 min over 1 h, and finally, the hybridization was developed with fresh NBT/BCIP mix (Roche).
Knockdown of opioid receptors
Antisense morpholino oligonucleotides (MOs) of opioid receptors were used to knock down opioid receptors (Gene Tools, Philomath, OR, USA) in order to determine the relationship between opioid and TACRs (tacr1a and tacr1b expression). Approximately 3 nl of MOs were microinjected into the yolks of zebrafish embryos at the one-to four-cell stage with a micromanipulator-microinjector system from Eppendorf AG (Hamburg, Germany). The MO experimental groups (ZfMOR, ZfDOR1, ZfDOR2, and ZfDOR1-ZfDOR2) were compared with the MO control groups (microinjected with a standard MO control solution and embryos without microinjections). The following MO sequences were used: ZfMOR (AATGTTGC-CAGTGTTTTCCATCATG), ZfDOR1 (GAATGACGGACGG-CTCCATCGCTTC), and ZfDOR2 (GGAGGCTCCATTAT-GCTCGTCCCCT). The MO concentrations used for the different opioid receptors were 0.2 mM (ZfMOR), 1 mM (ZfDOR1), 1 mM (ZfDOR2), and 1 mM (ZfDOR1-ZfDOR2).
Statistical analyses
The results are presented as means of transcriptsGS.E.M. of the values. Pairs of the data were analyzed by Student's t-test while multiple comparisons were evaluated by ANOVA. Follow-up analysis was performed using the Dunnet test for multiple comparisons. Differences were considered significant at P!0.05. All statistical analyses were performed with Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA).
Results
Full-length tacr1a and tacr1b cloning in zebrafish After RNA isolation from 48-hpf zebrafish embryos, PCR amplification, cloning, and sequencing, we obtained the full-length cDNA of two genes, which were designated 
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Research R LÓ PEZ-BELLIDO and others Tachykinin receptor 1 subtypes in zebrafish tacr1a (1281 bp; GenBank ID: 33455) and tacr1b (1239 bp; GenBank ID: 345672) ( Fig. 1A, B and C). The ORFs of the tacr1a and tacr1b genes encoded proteins of 426 (predicted molecular weight of 48.96 kDa) and 412 amino acids (40.53 kDa) respectively (Fig. 2 ). Tacr1a and Tacr1b exhibited characteristic seven transmembrane domains (TMs), two consensus sites for N-glycosylation sites for Tacr1a (Asn 13 and Asn 17 ), and one possible site for Tacr1b (Asn 14 ) in the N-terminal extracellular domain (N-terminal), together with two conserved Cys residues for Tacr1a (Cys 111 and Cys 186 ) and for Tacr1b (Cys 112 and Cys 187 ), which can form a disulfide bond between the first and second extracellular loops. The NK receptors also showed putative phosphorylation sites on serine or threonine residues: in the N-terminal, in the first intracellular loop (IL1), in IL2, in IL3; in the carboxyl terminal domain (C-terminal), and a potential palmitoylation site on Cys residues for Tacr1a (Cys 329 ) and for Tacr1b (Cys 330 ) in the C-terminal domain. Moreover, Tacr1a and Tacr1b had a typical DRY motif at the border between TM3 and IL2 and a K/RK/RXXK/R moiety in IL3 (Fig. 2) . The Ensembl database (http://www.ensembl.org/) revealed that the tacr1a and tacr1b genes were found on chromosomes 5 and 11 respectively and formed by five exons. The zebrafish Tacr1a and Tacr1b homology with respect to human, rat, and mouse (TACR1) was 66% and when it was compared between them (Tacr1a and Tacr1b) it was 75%.
Phylogenetic analysis of zebrafish Tacr1a and Tacr1b
A clear demarcation was found between zebrafish Tacr1s (Tacr1a and Tacr1b), Tacr2, and Tacr3, and their orthologs, supported by bootstrap values of 100, 48, and 99% (NJ; Fig. 3A ) and 55, 70, and 94% (ML; Fig. 3B ). The zebrafish Tacr2 (predicted sequence) and Tacr3 (Zhou et al. 2012) amino acid sequences were used to check whether Tacr1a and Tacr1b could be aligned in Tacr2 or Tacr3 clusters and might not be duplicate genes. The phylogenetic analyses showed that Tacr1a and Tacr1b were aligned in the same cluster of Tacr1s, suggesting that Tacr1a and Tacr1b  receptors are duplicate genes and paralogs of the Tacr2  and Tacr3 from zebrafish and orthologs of the TACR1,  TACR2 , and TACR3 of several species. We performed a double phylogenetic analysis using two different methods in order to corroborate that the replication of the alignment of the branches was indeed due to the divergence of the amino acid sequences, rather than to the phylogenetic algorithms employed. The zebrafish opioid receptors ZfMOR (NP_571782.1), ZfDOR1 (NP_571333.1), ZfDOR2 (NP_997920.1), and ZfKOR (NP_878306.1) were included as out-groups, as these and TACR1 belong to the GPCR superfamily (Herrero-Turrion & Rodriguez 2008) and, additionally, both of them are involved in pain and analgesic processes respectively.
The following species (with their respective accession number) were employed to perform the phylogenetic analyses in the case of TAC1R: human (NP_001049.1), dog (NP_001012637.1), guinea pig (NP_001166332.1), rat (NP_036799.1), mouse (NP_033339.2), chicken (NP_990199.1), frog (NP_001106489.1; Xenopus tropicalis), fugu (AAQ02694), zebrafish Tacr1a (GenBank ID: 33455), and zebrafish Tacr1b (GenBank ID: 345672; also named Nk1a and Nk1b respectively); for TACR2: human (NP_001048.2), rat (NP_542946.1), mouse (NP_033340.2), and zebrafish Tacr2 (XP_001341981.1) (predicted sequence); in the case of TACR3: human (NP_001050.1), rat (NP_058749.1), mouse (NP_067357.1), and zebrafish Tacr3a1, Tacr3a2, and Tacr3b (Zhou et al. 2012) .
Temporal expression of tacr1a and tacr1b during embryogenesis
In this study, the mRNA expression of tacr1a was gradually increased from 8 to 72 hpf (Fig. 4A ), except at 48 hpf, when tacr1a mRNA decreased with respect to 30 hpf. By contrast, the mRNA of tacr1b displayed a different expression pattern with respect to tacr1a (Fig. 4B) . At early developmental stages, from 8 to 22 hpf, no marked changes were observed. When the CNS had been formed at 24 hpf, tacr1b showed a threefold increase with respect to 22 hpf. The expression of tacr1b decreased from 24 to 48 hpf. In addition, at 72 hpf, we observed that tacr1b reached the maximum peak of expression with respect to all the developmental stages studied (Fig. 4B) .
The 8 hpf stage was selected because at this moment, there is a reliable mRNA expression with no maternal interference. During the early stages of 16, 19, and 22 hpf, the segmentation and differentiation of the CNS are taking place and at 24 hpf, the zebrafish already have the five lobes (telencephalon, diencephalon, epiphysis, midbrain, and cerebellum) that conform the CNS. Organogenesis takes place between 24 and 48 hpf, and at 48 hpf, the morphogenesis of the primary organ systems has been completed. The end of embryonic development occurs at 72 hpf.
tacr1a and tacr1b mRNA spatial expression at 24 and 48 hpf
The tacr1a transcript was detected at 24 hpf in different areas of the CNS (telencephalon, hypothalamus, diencephalon,midbrain,midbrain-hindbrainboundary(MHB), and hindbrain) and also peripherally in the somites (Fig. 5A and B) . The expression of tacr1b at 24 hpf, like that of tacr1a, was found in the CNS (Fig. 5E and F ; telencephalon, hypothalamus, diencephalon, MHB, midbrain, hindbrain, and spinal cord) and at the periphery (somites). At 48 hpf, tacr1a showed a similar pattern of expression in the CNS to that at 24 hpf and it was also expressed in the medial longitudinal fasciculus (MLF). At the periphery, expression was less than at 24 hpf but was observed in somites ( Fig. 5C and D) . tacr1b transcripts at the 48 hpf stage ( Fig. 5G and H) were also present in the CNS, similar to at 24 hpf, although with higher expression and with no expression in the spinal cord. At this stage, tacr1b was also expressed in the MLF and somites ( Fig. 5G and H; but less intensely than at 24 hpf).
Effects of cocaine on the temporal expression of tacr1a
and tacr1b
Embryos exposed to cocaine (at 5 hpf) and analyzed at 24 hpf showed a twofold increase in the expression of tacr1a with respect to the control group (P!0.0001; Fig. 6A ). Also, the expression of tacr1b was increased by the actions of cocaine: threefold higher with respect to the control group (PZ0.0194; Fig. 6B ). At 48 hpf, cocaine decreased the expression of tacr1a (PZ0.0006; Fig. 6A ). Conversely, cocaine led to a twofold increase in the expression levels of tacr1b (P!0.0359; Fig. 6B ), in both cases with respect to the control group.
Knockdown of ZfMOR, ZfDOR1, and ZfDOR2 and effects on tacr1a and tacr1b expression
Knockdown of the ZfDOR2 opioid receptor with a MO elicited nearly eight times less expression of tacr1a at 48 hpf with respect to the control group (PZ0.0010; Fig. 7A ) and the MO control group. Conversely, ZfMOR MO microinjection induced a fourfold increase in the expression of tacr1b (P!0.0001; Fig. 7B ) in comparison with the control and MO control groups. The ZfDOR1 and ZfDOR1/2 did not induce changes in the expression of any tacr1s.
Effects of cocaine on the level of expression of tacr1a and tacr1b transfected into HEK-293 cells HEK-293 cells transfected with tacr1a and tacr1b coupled to pEGFP-C3 and pDsRed-N-1 respectively did not reveal morphological changes in tacr1 ( Fig. 8A and B) and tacr1b ( Fig. 8C and D) due to exposure to cocaine. Nevertheless, PCR results showed that cocaine decreased the expression levels of tacr1a ( Fig. 8E) and tacr1b (Fig. 8F ). This decrease, especially that of tacr1a, being noteworthy (Fig. 8E) . We have also corroborated by qPCR that cocaine decreased the expression level of tacr1a dramatically (P!0.0001; Fig. 8I ), and in the case of tacr1b, the changes produced by cocaine were more apparent than those observed before in the PCR experiment ( Fig. 8F) , as cocaine elicited a reduction (P!0.0001; Fig. 8I ). Before exposure to cocaine, we evaluated the toxic effect of cocaine on HEK-293 cells by microscopy observations and we did not find changes of cell viability in cocaine-treated and -untreated groups of cells. The doses of 0.5, 1.5, and 3 mM were used and none produced toxicity in the cell culture. Moreover, we studied the expression of the reference gene (GAPDH) by PCR and qPCR ( Fig. 8A and B respectively) , where this reference gene does not exhibit consistent changes. This indicates that the effects of cocaine altered the expression of tacr1 genes and is not related to the toxicity of cocaine on the HEK-293 cells.
Discussion
In this study, the tacr1a and tacr1b genes in zebrafish, which are duplicate genes of the TAC1R gene in mammals have been identified (Pennefather et al. 2004 ). The phylogenetic trees generated with the NJ and ML methods show that these receptors have a monophyletic origin, as the three TACRs derive from a common gene.
In vertebrates, there are three TACRs (TACR1, TACR2, and TACR3; Pennefather et al. 2004 ) that were originated during evolution by duplications of a single ancestral receptor. In addition, both phylogenetic trees suggest that the TACRs (related to the pain process) were originated before the development of opioid receptors (analgesic receptors) during evolution, suggesting that during phylogenetic evolution first appeared pain and after its regulatory mechanism system. Expression of tacr1a (A) and tacr1b (B). qPCR analyses of transcript levels of neurokinin receptors were performed at several development stages: 8, 16, 19, 22, 24, 30, 48, and 72 hpf. Gene expression levels were measured by fluorescence intensities using qPCR. The reference gene used to normalize the expression of the different genes studied by qPCR was ef1a (NM_131263.1). Two hundred embryos were used to extract RNA and synthesize cDNA. Error bars represent means of mRNA copies at each developmental stageGS.E.M. Three independent experiments (each performed three times) were conducted for each stage.
Tacr1a and Tacr1b, displayed characteristics of the seven TM receptor, the two consensus sites for N-glycosylation sites in the human TAC1R (Asn 14 and Asn 18 ; Takeda et al. 1991) are conserved in zebrafish Tacr1a (Asn 13 and Asn 17 ) but not in Tacr1b, where the asparagine residues are substituted by Asp 14 and Ala 18 (Fig. 2) . This difference in the N-glycosylation pattern between TACR1a and TACR1b could involve changes in the bioactivity of Tacr1b and affect its physical stability as the glycosylation of TACR1 may stabilize the receptor at the plasma membrane (Tansky et al. 2007) . Two amino acid residues -Val 116 and Ile 290 -in the human TACR1 (Fong et al. 1992a) are conserved in zebrafish Tacr1a (Val 122 and Ile 296 ) and Tacr1b (Val 123 and Ile 297 ) receptors and are not present in the rat or mouse, where they are substituted by Leu 116 and Ser 290 . These residues appear to be determinant for the binding of the selective non-peptide antagonist CP 96 345 on the TACR1 type and they are also important in the differentiation between species (Fong et al. 1992b ). The replacement of Val 116 and Ile 290 of the human TACR1 by Leu 116 and Ser 290 in the rat confers sensitivity to the TACR1 antagonist RP 67 580. Likewise, a non-peptide TACR1 antagonist, WIN 51 708, binds to the rat TACR1type receptor but not to the human TACR1. This binding is mediated by Ser 290 in the rat TACR1 while human TACR1 has Ile 290 (Venepalli et al. 1992) . As zebrafish Tacr1a and Tacr1b have residues of isoleucine (Ile 296 and Ile 297 respectively; Fig. 2 ), this organism would be an alternative model in the study of TACR1 antagonist in the field of pain. Additionally, the potential putative phosphorylation sites on serine or threonine residues in zebrafish Tacr1a and Tacr1b show that these receptors may be able to shed new light on the desensitization and internalization of TACR1. It is controversial if fishes feel pain, but during the last decade, important evidence has been shown concerning the fact that fishes can perceive pain. Distribution of tacr1a and tacr1b at 24 and 48 hpf in embryos by wholemount ISH. tacr1a is present in the telencephalon, diencephalon, midbrainhindbrain boundary, hindbrain, and somites at 24 hpf (A and B) . tacr1b is present in telencephalon, diencephalon, midbrain, hindbrain, spinal cord, and somites at 24 hpf (E and F). Lateral views (C and D) show that tacr1a is present in the telencephalon, diencephalon, midbrain, MLF, hindbrain, heart, and somites. In the case of tacr1b (G and H), it is present in the telencephalon, diencephalon, midbrain, MLF, hindbrain, spinal cord, and somites. Control group (I, J, K and L). All the embryos of the control group, from both tacr1a and tacr1b, did not show staining; for this reason, we only included one control group. Scale bar, 250 mm; 6! magnification in A, C, E, G, I, and K and 12! magnification in B, D, F, H, J, and L. In this sense, the goldfish (Carassius auratus) and rainbow trout (Oncorhynchus mykiss) have been reported to present nociceptors that respond to mechanical, thermal, and chemical stimulations (Sneddon 2003a , Dunlop & Laming 2005 , Ashley et al. 2007 ) and morphine reduced dramatically the behavioral and physiological responses after injection of a noxious stimulus (Sneddon 2003b) . As a teleost fish, zebrafish, has an analgesic system, opioid system (Gonzalez-Nunez & Rodriguez 2009), and according to our findings, this organism also has the receptor of SP, Tacr1a and Tacr1b. It can be deduced that this organism through this nociceptive and tachykinin system can feel pain. Unfortunately, at present, a prototypic behavioral pain model in zebrafish has not been developed, as in mouse and rat, to corroborate the molecular and electrophysiological findings of pain in fishes (Sneddon 2003a , Dunlop & Laming 2005 , Ashley et al. 2007 . However, all the recent studies using the zebrafish as a model point to this organism as a new potential model in the study of pain. One interesting finding of our work is that the expression of tacr1a (Fig. 4A) is increasing since the early zebrafish stages of development (8 hpf, gastrulation) until the end of the CNS development (w24 hpf), primary organogenesis (48 hpf), and embryogenesis (72 hpf), suggesting that these receptors are involved in the formation of the CNS, organogenesis, and embryogenesis in general. This fact is in agreement with studies that SP, ligand of the TACR1, is increasing in number during embryonic development of the CNS (Gilbert & Emson 1979) . Moreover, it has been reported that TAC1R could be important in the development of motorneurons in the rat during embryonic development (St John & Stephens 1992 , St John et al. 1997 . One characteristic shared between tacr1a and tacr1b is that both are expressed at high levels at 72 hpf, although the expression of tacr1a is almost threefold higher with respect to tacr1b ( Fig. 4A and B) . Also, during several embryonic stages of development, tacr1a mRNA expression was greater than tacr1b. This fact suggests that tacr1a could have a major role, during zebrafish embryogenesis, in comparison to tacr1b, as a subfunctionalization of the gene can occur after a gene duplication event (Postlethwait 2007) .
In zebrafish, tacr1a and tacr1b (Fig. 5) were mainly expressed at 24 hpf in the CNS (telencephalon, midbrain, diencephalon, hypothalamus, and hindbrain) and the peripheral (nervous system somites), with the difference that tacr1b was also expressed in the spinal cord. The expression of tacr1b in the spinal cord is consistent with the findings of TACR1 (mRNA) expression in the rat spinal cord (McCarson & Krause 1994 , McCarson 1999 , Todd et al. 2002 , Gamboa-Esteves et al. 2004 ), suggesting that in the spinal cord tacr1b might play a major role in comparison with tacr1a.
There is evidence of interaction of DOR/PPTA, as it has been reported that DOR coexist with PPTA, in the rat dorsal root ganglia in the primary afferent neurons (Minami et al. 1995) and PPTA can modulate the sensitivity of nociceptive afferents to opioids (Guan et al. 2005) . In the present work, we report that knockdown of ZfDOR2 downregulates the expression of tacr1a, which suggests that DOR/TAC1R can have an important role during embryonic development and also in pain modulation (Minami et al. 1995 , Guan et al. 2005 . The difference of our work in relation to Minami et al. (1995) and Guan et al. (2005) is that we studied the mRNA Effects of cocaine on the expression levels of tacr1a (A) and tacr1b (B) at 24 and 48 hpf. Two hundred embryos were used to extract RNA and synthesize cDNA. Error bars represent means of mRNA copies at each developmental stageGS.E.M. Three independent experiments (each carried out three times) were performed for each stage. P values were calculated by a two-tailed unpaired Student's t-test: *P!0.05 and ***P!0.001. expression (of Tacr1a and Tacr1b) in whole-mount zebrafish embryos in one stage of embryonic development (48 hpf) while the other studies were done in adult rats and mice. Also, several studies have described that TACR1/MOR functionally interact and mediate the regulation of MOR-TACR1 trafficking, where the activation of TACR1 by SP can induce or inhibit the endocytosis of MOR (Pfeiffer et al. 2003 , Yu et al. 2009 ). Our results show that downregulation of ZfMOR increases the expression of tacr1b, suggesting that MOR could be positively regulating TACR1. According to our results, a possible mechanism of ZfDOR2 and ZfMOR antisense knockdown leading to changes in expression of tacr1a and tacr1b could be explained as an interaction of these receptors in the cell membrane or gene expression, but these postulates have to corroborate with future studies.
The importance of our research is that the tachykinin system and the opioid receptors are closely related, where changes induced in the tachykinin system could modify the functions of opioid receptors. As DOR and MOR interact (in the cell membrane) and DOR modulates the function of MOR (Gomes et al. 2004) , TACRs (via MOR or indirectly via DOR) would modulate the activity of the opioid receptors. In this study, the knockdown of ZfDOR2 and ZfMOR regulated the expression of tacr1a and tacr1b respectively, indicating that tachykinin and the opioid systems are closely interrelated in zebrafish, as has been described in mammals (Minami et al. 1995 , Pfeiffer et al. 2003 , Guan et al. 2005 , Yu et al. 2009 ). As the set of MOs of opioid receptors was effective, as previously demonstrated by Sanchez-Simon et al. (2010) , and replicated in our study, we are convinced that the changes on the expression of the TACRs are a consequence of the downregulation of the opioid receptors. As we are studying the changes of gene expression in vivo whole-mount zebrafish embryos, it is difficult to know whether the effects that we observe are specifically produced by opioid receptors as other genes or elements can also regulate both the opioid and the tachykinin system. SP is considered a neurotransmitter of the primary sensory neurons that mediate the synaptic transmission of pain (Otsuka & Yoshioka 1993 , Seybold 2009 ), which means that changes observed by cocaine actions in the mRNA expression of tacr1a and tacr1b ( Fig. 6A and B respectively) could affect pain processes and alterations in the development of pain and hyperalgesia (Stanley & Safford 2004 ) such as in embryogenesis. Conversely, our results show that cocaine exerts different actions in human cells and in zebrafish embryos, probably because in whole organisms cocaine must cross different barriers before exerting its actions on its targets, and also, it should be considered that it can be metabolized. As cocaine presents a high liposolubility, this drug rapidly passes through the cell membrane by passive transport (Schenker et al. 1993) ; this could explain the alterations of the expression of the tacr1a/b genes transfected in the HEK-293 cells. It would be interesting to study the amount of cocaine that is passing through the HEK-293 cell membrane. Moreover, according to our previous study, w12% 1.5 mM cocaine is passing the chorion of zebrafish embryos (R Ló pez-Bellido, K Barreto-Valer, FM Sanchez-Simon & RE Rodriguez 2012, unpublished observations) and up to 80% the placenta (Schenker et al. 1993) . Thus, as we found that 1.5 mM cocaine did not induce toxicity in the HEK-293 cells and produced no evident changes in the expression of tacr1a and tacr1b and the reference gene HEK-293 cells expressing tacr1a and tacr1b from zebrafish. HEK-293 cells were transfected with tacr1a-GFP receptor (A and B) and tacr1b-DsRed receptor (C and D). The pictures on the left and on the right correspond to the control (A and C) and cocaine groups (B and D) respectively. Scale bar, 100 mM. The pictures were taken using epifluorescent microscope (Eclipse TE2000-S, Nikon). Cocaine induced a decrease in tacr1a (E) and tacr1b (F), GAPDH was used as a reference gene for both tacr1a (G) and tacr1b (H) expression in the PCR results. Effects of cocaine on the expression of tacr1a and tacr1b (I and J) analyzed by qPCR. Cocaine induced a decrease in tacr1a and tacr1b expression (I), GAPDH was used as a reference gene (J). Three independent experiments, each performed three times, were carried out. P values were calculated by unpaired two-tailed Student's t-test: ***P!0.001.
